EP2373681
Lyfjasamsetningar albíglútíðs
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
10.12.2009EP published:
18.1.2017EP application number:
09832522.8
EP translation filed:
27.2.2017Grant published:
15.3.2017EPO information:
European Patent Register
Max expiry date:
9.12.2029Expiry date:
9.12.2023
Title:
PHARMACEUTICAL COMPOSITIONS OF ALBIGLUTIDE
Timeline
Today
10.12.2009EP application
18.1.2017EP Publication
27.2.2017Translation submitted
15.3.2017Registration published
9.12.2023Expires
Owner
Name:
GlaxoSmithKline LLCAddress:
Corporation Service Company 2711 Centerville Road Suite 400, 19808, Wilmington , DE, US
Inventor
Name:
BUSH, Mark, A.Address:
Research Triangle Park, NC, US
Name:
STEWART, Murray, W.Address:
King Of Prussia, PA, US
Name:
YANG, YonghongAddress:
King Of Prussia, PA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
121229 PDate:
10.12.2008Country:
US
Number:
238723 PDate:
1.9.2009Country:
US
Number:
163995 PDate:
27.3.2009Country:
US
Number:
150909 PDate:
9.2.2009Country:
US
Classification
Categories:
C07K 14/605, A61K 38/26, A61K 45/06
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 13.11.2017
Expires: 9.12.2018
Payer: Örn Þór, slf.
Number: 10
Paid: 30.9.2018
Expires: 9.12.2019
Payer: Örn Þór, slf.
Number: 11
Paid: 14.11.2019
Expires: 9.12.2020
Payer: Örn Þór, slf.
Number: 12
Paid: 11.11.2020
Expires: 9.12.2021
Payer: Örn Þór slf.
Number: 13
Paid: 17.11.2021
Expires: 9.12.2022
Payer: Patice ehf.
Number: 14
Paid: 22.11.2022
Expires: 9.12.2023
Payer: Árnason Faktor ehf.